FDA may grant emergency use of a vaccine before trials end; Most Americans believe COVID-19 vaccine approval is driven by politics; Aimmune to be acquired by Nestle.
Mark Read on reopening offices, job cuts, Accenture and his $64 expenses
Nursing home guidelines require testing for staff, residents; Justice Department to charge Teva in price-fixing probe; Verily launches subsidiary focused on stop-loss health insurance.
Five things for pharma marketers to know: Tuesday, August 25, 2020
FDA grants emergency use authorization for plasma in treatment of COVID-19; NIH to study another Gilead coronavirus drug candidate; First documented case of reinfection with COVID-19 raises questions.
Five things for pharma marketers to know: Thursday, August 20, 2020